These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 25649862)
41. Rucaparib antagonize multidrug resistance in cervical cancer cells through blocking the function of ABC transporters. Chen Z; Ling K; Zhu Y; Deng L; Li Y; Liang Z Gene; 2020 Oct; 759():145000. PubMed ID: 32717310 [TBL] [Abstract][Full Text] [Related]
42. Pharmacogenetics of ATP-binding cassette transporters and clinical implications. Cascorbi I; Haenisch S Methods Mol Biol; 2010; 596():95-121. PubMed ID: 19949922 [TBL] [Abstract][Full Text] [Related]
43. Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition. Dewanjee S; Dua TK; Bhattacharjee N; Das A; Gangopadhyay M; Khanra R; Joardar S; Riaz M; Feo V; Zia-Ul-Haq M Molecules; 2017 May; 22(6):. PubMed ID: 28587082 [TBL] [Abstract][Full Text] [Related]
44. Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells. Mo L; Pospichalova V; Huang Z; Murphy SK; Payne S; Wang F; Kennedy M; Cianciolo GJ; Bryja V; Pizzo SV; Bachelder RE PLoS One; 2015; 10(7):e0131579. PubMed ID: 26148191 [TBL] [Abstract][Full Text] [Related]
45. The medicinal chemistry of multidrug resistance (MDR) reversing drugs. Teodori E; Dei S; Scapecchi S; Gualtieri F Farmaco; 2002 May; 57(5):385-415. PubMed ID: 12058813 [TBL] [Abstract][Full Text] [Related]
46. Poloxamines display a multiple inhibitory activity of ATP-binding cassette (ABC) transporters in cancer cell lines. Cuestas ML; Sosnik A; Mathet VL Mol Pharm; 2011 Aug; 8(4):1152-64. PubMed ID: 21591727 [TBL] [Abstract][Full Text] [Related]
47. The Tetrahydroisoquinoline Scaffold in ABC Transporter Inhibitors that Act as Multidrug Resistance (MDR) Reversers. Teodori E; Braconi L; Manetti D; Romanelli MN; Dei S Curr Top Med Chem; 2022; 22(31):2535-2569. PubMed ID: 36284399 [TBL] [Abstract][Full Text] [Related]
48. Arylamino Esters As P-Glycoprotein Modulators: SAR Studies to Establish Requirements for Potency and Selectivity. Teodori E; Dei S; Floriddia E; Perrone MG; Manetti D; Romanelli MN; Contino M; Colabufo NA ChemMedChem; 2015 Aug; 10(8):1339-43. PubMed ID: 26012726 [TBL] [Abstract][Full Text] [Related]
49. The phytoestrogen genistein enhances multidrug resistance in breast cancer cell lines by translational regulation of ABC transporters. Rigalli JP; Tocchetti GN; Arana MR; Villanueva SS; Catania VA; Theile D; Ruiz ML; Weiss J Cancer Lett; 2016 Jun; 376(1):165-72. PubMed ID: 27033456 [TBL] [Abstract][Full Text] [Related]
50. Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multidrug resistance 1, and OATP1B1/breast cancer resistance protein. Matsushima S; Maeda K; Kondo C; Hirano M; Sasaki M; Suzuki H; Sugiyama Y J Pharmacol Exp Ther; 2005 Sep; 314(3):1059-67. PubMed ID: 15901800 [TBL] [Abstract][Full Text] [Related]
51. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo. Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876 [TBL] [Abstract][Full Text] [Related]
52. Lipid regulation of the ABCB1 and ABCG2 multidrug transporters. Hegedüs C; Telbisz Á; Hegedűs T; Sarkadi B; Özvegy-Laczka C Adv Cancer Res; 2015; 125():97-137. PubMed ID: 25640268 [TBL] [Abstract][Full Text] [Related]
53. Sonic Hedgehog promotes multiple drug resistance by regulation of drug transport. Sims-Mourtada J; Izzo JG; Ajani J; Chao KS Oncogene; 2007 Aug; 26(38):5674-9. PubMed ID: 17353904 [TBL] [Abstract][Full Text] [Related]
54. Novel structure-activity relationships and selectivity profiling of cage dimeric 1,4-dihydropyridines as multidrug resistance (MDR) modulators. Coburger C; Wollmann J; Krug M; Baumert C; Seifert M; Molnár J; Lage H; Hilgeroth A Bioorg Med Chem; 2010 Jul; 18(14):4983-90. PubMed ID: 20598550 [TBL] [Abstract][Full Text] [Related]
55. Natural products as multidrug resistance modulators in cancer. Kumar A; Jaitak V Eur J Med Chem; 2019 Aug; 176():268-291. PubMed ID: 31103904 [TBL] [Abstract][Full Text] [Related]
56. HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2). Köhler SC; Wiese M J Med Chem; 2015 May; 58(9):3910-21. PubMed ID: 25855895 [TBL] [Abstract][Full Text] [Related]
57. Novel tetrahydroisoquinolin-ethyl-phenylamine based multidrug resistance inhibitors with broad-spectrum modulating properties. Jekerle V; Klinkhammer W; Reilly RM; Piquette-Miller M; Wiese M Cancer Chemother Pharmacol; 2007 Jan; 59(1):61-9. PubMed ID: 16636798 [TBL] [Abstract][Full Text] [Related]
58. The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade. Kathawala RJ; Gupta P; Ashby CR; Chen ZS Drug Resist Updat; 2015 Jan; 18():1-17. PubMed ID: 25554624 [TBL] [Abstract][Full Text] [Related]
59. Revisiting the ABCs of multidrug resistance in cancer chemotherapy. Tiwari AK; Sodani K; Dai CL; Ashby CR; Chen ZS Curr Pharm Biotechnol; 2011 Apr; 12(4):570-94. PubMed ID: 21118094 [TBL] [Abstract][Full Text] [Related]
60. Role of ATP-binding cassette (ABC) transporters in interactions between natural products and drugs. Aszalos A Curr Drug Metab; 2008 Dec; 9(10):1010-8. PubMed ID: 19075617 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]